Complement component C9 [Cleaved into: Complement component C9a; Complement component C9b]
| GO Term | Evidence Code | Reference |
|---|---|---|
| cell killing | ||
| complement activation | ||
| complement activation | ||
| complement activation, alternative pathway |
|
|
| complement activation, classical pathway |
|
|
| GO Term | Evidence Code | Reference |
|---|---|---|
| extracellular region | ||
| extracellular region | ||
| extracellular region | ||
| extracellular region | ||
| membrane attack complex |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 24 |
|
|||
| 26 |
|
|||
| 32 |
|
|||
| 48 |
|
|
||
| 51 |
|
|
||
| 123 |
|
|
||
| 258 |
|
|||
| 277 |
|
|||
| 415 |
|
|
||
| 518 |
|
|
| Pathway Name | Organism |
|---|---|
| Regulation of Complement cascade | Homo sapiens |
| Terminal pathway of complement | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:2559 | opiate dependence | |
| DOID:0110027 | age related macular degeneration 15 | |
| DOID:0060303 | complement component 9 deficiency |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026